- Consumer Products
- Latest 55.18
- Currency US$
- Change 0.88
- Percent Change 1.621 %
- Volume 1,345,291
- Tue Jul 22, 2014 01:12 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||May 1||$1.23||Jul 31||$1.20|
12 months ended Jul 22, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.